Clinical and histological findings after intravitreal injection of bevacizumab (Avastin®) in a porcine model of choroidal neovascularization

Acta Ophthalmologica

Volumn 88, Issue 3, 2010, Pages 300-308

  Lassota, Nathan ^a   Prause, Jan Ulrik ^a   Scherfig, Erik ^a,b   Kiilgaard, Jens Folke ^a,b   La Cour, Morten ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

AMD; Animal model; Avastin; Bevacizumab; CNV; RPE

Indexed keywords

BEVACIZUMAB; GROWTH FACTOR; PLACEBO; RINGER LACTATE SOLUTION;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRUCH MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; ENDOTHELIUM CELL; ENUCLEATION; FEMALE; HISTOPATHOLOGY; KIDNEY BLOOD VESSEL; MUELLER CELL; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA GANGLION CELL; SUBRETINAL NEOVASCULARIZATION; TREATMENT RESPONSE; VASCULAR ENDOTHELIUM;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBODIES, MONOCLONAL; CAPILLARY PERMEABILITY; CHOROIDAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FEMALE; FLUORESCEIN ANGIOGRAPHY; IMMUNOENZYME TECHNIQUES; INJECTIONS; MICROSCOPY, FLUORESCENCE; SWINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITRECTOMY; VITREOUS BODY;

EID: 77951702073     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2008.01439.x     Document Type: Article

References (36)

1. Bakri SJ, Snyder MR, Reid JM, Pulido JS Singh RJ (2007 Pharmacokinetics of intravitreal bevacizumab (Avastin). Ophthalmology 114 : 855 859.
2. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP Schneider S (2006 Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355 : 1432 1444.
3. Chianini F, Majo N, Segales J, Dominguez J Domingo M (2001 Immunohistological study of the immune system cells in paraffin-embedded tissues of conventional pigs. Vet Immunol Immunopathol 82 : 245 255.
4. Chin HS, Park TS, Moon YS Oh JH (2005 Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and non-vitrectomized eyes. Retina 25 : 556 560.
5. la Cour M (2007 Intravitreal VEGF-inhibitors: is Avastin a generic substitute for Lucentis? Acta Ophthalmol Scand 85 : 2 4.
6. Emerson MV, Lauer AK, Flaxel CJ et al. (2007 Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration. Retina 27 : 439 444.
7. Famiglietti EV, Stopa EG, McGookin ED, Song P, LeBlanc V Streeten BW (2003 Immunocytochemical localization of vascular endothelial growth factor in neurons and glial cells of human retina. Brain Res 969 : 195 204.
8. Forstreuter F, Lucius R Mentlein R (2002 Vascular endothelial growth factor induces chemotaxis and proliferation of microglial cells. J Neuroimmunol 132 : 93 98.
9. Geitzenauer W, Michels S, Prager F, Kornek G, Vormittag L, Rosenfeld P Schmidt-Erfurth U (2006 [Early effects of systemic and intravitreal bevacizumab (Avastin) therapy for neovascular age-related macular degeneration.] Klin Monatsbl Augenheilkd 223 : 822 827. (Pubitemid 44860922)
10. Gibran SK, Sachdev A, Stappler T, Newsome R, Wong D Hiscott P (2007 Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin). Br J Ophthalmol 91 : 602 604.
11. Gragoudas ES, Adamis AP, Cunningham ET Jr., Feinsod M Guyer DR (2004 Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351 : 2805 2816.
12. Grossniklaus HE Green WR (2004 Choroidal neovascularization. Am J Ophthalmol 137 : 496 503.
13. Heiduschka P, Fietz H, Hofmeister S et al. (2007 Penetration of bevacizumab through the retina after intravitreal injection in the monkey. Invest Ophthalmol Vis Sci 48 : 2814 2823.
14. Howdieshell TR, Callaway D, Webb WL et al. (2001 Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation. J Surg Res 96 : 173 182.
15. Ishibashi T, Hata Y, Yoshikawa H, Nakagawa K, Sueishi K Inomata H (1997 Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 235 : 159 167.
16. Jonas JB, Libondi T, Ihloff AK, Harder B, Kreissig I, Schlichtenbrede F, Sauder G Spandau UH (2007 Visual acuity change after intravitreal bevacizumab for exudative age-related macular degeneration in relation to subfoveal membrane type. Acta Ophthalmol Scand 85 : 563 565.
17. Kaiser PK, Blodi BA, Shapiro H Acharya NR (2007 Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 114 : 1868 1875.
18. Kiilgaard JF (2002 Implantation of basement membranes in the subretinal space in pigs. Repair of damaged Bruch's membrane to prevent neovascular subretinal neovascular scar formation. Thesis : 1 90.
19. Kiilgaard JF, Wiencke AK, Scherfig E, Prause JU la Cour M (2002 Transplantation of allogenic anterior lens capsule to the subretinal space in pigs. Acta Ophthalmol Scand 80 : 76 81.
20. Kiilgaard JF, Andersen MV, Wiencke AK, Scherfig E, la Cour M, Tezel TH Prause JU (2005 A new animal model of choroidal neovascularization. Acta Ophthalmol Scand 83 : 697 704.
21. Krzystolik MG, Afshari MA, Adamis AP et al. (2002 Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol 120 : 338 346.
22. Kvanta A, Algvere PV, Berglin L Seregard S (1996 Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest Ophthalmol Vis Sci 37 : 1929 1934.
23. Lassota N, Kiilgaard JF, Prause JU la Cour M (2006 Correlation between clinical and histological features in a pig model of choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 244 : 394 398.
24. Lassota N, Kiilgaard JF, Prause JU, Qvortrup K, Scherfig E la Cour M (2007 Surgical induction of choroidal neovascularization in a porcine model. Graefes Arch Clin Exp Ophthalmol 245 : 1189 1198.
25. Lassota N, Kiilgaard JF, la Cour M, Scherfig E Prause JU (2008 Natural history of choroidal neovascularization after surgical induction in an animal model. Acta Ophthalmol 86 : 495 503.
26. Lopez PF, Sippy BD, Lambert HM, Thach AB Hinton DR (1996 Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci 37 : 855 868.
27. Pedersen R, Soliman W, Lund-Andersen H Larsen M (2007 Treatment of choroidal neovascularization using intravitreal bevacizumab. Acta Ophthalmol Scand 85 : 526 533.
28. Peters S, Julien S, Heiduschka P, Grisanti S, Ziemssen F, Adler M, Schraermeyer U Bartz-Schmidt KU (2007 Antipermeability and antiproliferative effects of standard and frozen bevacizumab on choroidal endothelial cells. Br J Ophthalmol 91 : 827 831.
29. Roberts WG Palade GE (1995 Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108 : 2369 2379.
30. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY Kim RY (2006 Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355 : 1419 1431.
31. Saxe SJ, Grossniklaus HE, Lopez PF, Lambert HM, Sternberg P Jr. L'Hernault N (1993 Ultrastructural features of surgically excised subretinal neovascular membranes in the ocular histoplasmosis syndrome. Arch Ophthalmol 111 : 88 95. (Pubitemid 23022895)
32. Schmidt-Erfurth UM, Richard G, Augustin A et al. (2007 Guidance for the treatment of neovascular age-related macular degeneration. Acta Ophthalmol Scand 85 : 486 494. (Pubitemid 47163109)
33. Shahar J, Avery RL, Heilweil G et al. (2006 Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin). Retina 26 : 262 269.
34. Spaide RF, Laud K, Fine HF et al. (2006 Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 26 : 383 390. (Pubitemid 44197628)
35. Steinbrook R (2006 The price of sight - ranibizumab, bevacizumab, and the treatment of macular degeneration. N Engl J Med 355 : 1409 1412.
36. Winther H, Ahmed A Dantzer V (1999 Immunohistochemical localization of vascular endothelial growth factor (VEGF) and its two specific receptors, Flt-1 and KDR, in the porcine placenta and non-pregnant uterus. Placenta 20 : 35 43.